Published in Disease Risk Factor Week, July 3rd, 2005
Acute ischemic stroke is a treatable condition that requires urgent specialist attention because both thrombolytic drug treatment and specialist care of acute ischemic stroke have been shown to influence survival as well as recovery.
Randomized placebo-controlled studies have shown that thrombolysis with a clot-busting drug (rtPA-alteplase), administered within 3 hours of the onset of symptoms of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Disease Risk Factor Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.